The Influence of Biostatistics at the National Heart, Lung, and Blood Institute
暂无分享,去创建一个
[1] N. Geller,et al. Longitudinal clinical trials with adaptive choice of follow‐up time , 2015, Biometrics.
[2] Ralph B D'Agostino,et al. The randomized registry trial--the next disruptive technology in clinical research? , 2013, The New England journal of medicine.
[3] Colin O. Wu,et al. Nonparametric Estimation of Conditional Distributions and Rank-Tracking Probabilities With Time-Varying Transformation Models in Longitudinal Studies , 2013 .
[4] Jang Hwan Kim. Book Review: Fundamentals of Clinical Trials. 4th ed. , 2013, International Neurourology Journal.
[5] Colin O. Wu,et al. Preface. Randomized clinical trials. , 2012, Statistics in medicine.
[6] Colin O. Wu,et al. Joint Analysis of Binary and Quantitative Traits With Data Sharing and Outcome‐Dependent Sampling , 2012, Genetic epidemiology.
[7] Michael E. Miller,et al. Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes , 2011 .
[8] Correction for Multiplicity in Genetic Association Studies of Triads: The Permutational TDT , 2010, Annals of human genetics.
[9] N. Geller,et al. Prospective alpha allocation in the clarification of optimal anticoagulation through genetics (COAG) trial , 2010, Clinical trials.
[10] Song Yang,et al. Improved Logrank‐Type Tests for Survival Data Using Adaptive Weights , 2010, Biometrics.
[11] Maria Mori Brooks,et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.
[12] Neal O. Jeffries. Ranking Bias in Association Studies , 2009, Human Heredity.
[13] C. Sorkness,et al. Guideline-Defining Asthma Clinical Trials of the NHLBI ACRN and CARE Networks , 2009 .
[14] E. Leifer,et al. Use of biological assignment in hematopoietic stem cell transplantation clinical trials , 2008, Clinical trials.
[15] D. Goff,et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. , 2007, The American journal of cardiology.
[16] C. Kooperberg,et al. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials , 2007, Clinical trials.
[17] C. Sorkness,et al. Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. , 2007, The Journal of allergy and clinical immunology.
[18] Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program , 2005, Journal of Community Health.
[19] Patricia M. Grambsch,et al. Data Monitoring Committees in Clinical Trials: A Practical Perspective. , 2003 .
[20] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[21] The growing political movement against soft drinks in schools. , 2002, JAMA.
[22] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[23] David L. DeMets,et al. Data Monitoring Committees in Clinical Trials , 2002 .
[24] An application of the Zucker-Wittes modified ratio estimate statistic in the Post Coronary Artery Bypass Graft (CABG) clinical trial. , 1997, Controlled clinical trials.
[25] G. Bray,et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.
[26] E. J. Brown,et al. The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.
[27] Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. , 1997, The New England journal of medicine.
[28] Robert L. Frye,et al. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.
[29] J H Shih,et al. Sample size calculation for complex clinical trials with survival endpoints. , 1995, Controlled clinical trials.
[30] M A Proschan,et al. Designed extension of studies based on conditional power. , 1995, Biometrics.
[31] S. Kelder,et al. Statistical design of the Child and Adolescent Trial for Cardiovascular Health (CATCH): implications of cluster randomization. , 1995, Controlled clinical trials.
[32] T. Chalmers,et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.
[33] D A Follmann,et al. Monitoring multi-armed trials. , 1994, Statistics in medicine.
[34] D A Follmann,et al. Monitoring pairwise comparisons in multi-armed clinical trials. , 1994, Biometrics.
[35] L. Wilkins. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.
[36] E H Brittain,et al. Optimization of multistage testing times and critical values in clinical trials. , 1993, Biometrics.
[37] S. Yusuf,et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.
[38] D Zucker,et al. Testing the effect of treatment in experiments with correlated binary outcomes. , 1992, Biometrics.
[39] D. Zucker. The efficiency of a weighed log-rank test under a percent error misspecification model for the log hazard ratio. , 1992, Biometrics.
[40] N. Cook,et al. The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I , 1992 .
[41] K. Bailey,et al. Detecting fabrication of data in a multicenter collaborative animal study. , 1991, Controlled clinical trials.
[42] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[43] J. Wittes,et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.
[44] J. Bartko,et al. Proving the null hypothesis. , 1991 .
[46] D. Zucker,et al. Weighted log rank type statistics for comparing survival curves when there is a time lag in the effectiveness of treatment , 1990 .
[47] J. Ware,et al. Early methodological developments for clinical trials at the National Heart, Lung and Blood Institute. , 1990, Statistics in medicine.
[48] J. Verter. How much data should we collect in a randomized clinical trial? , 1990, Statistics in medicine.
[49] J. Wittes,et al. The role of internal pilot studies in increasing the efficiency of clinical trials. , 1990, Statistics in medicine.
[50] D L Demets,et al. Group sequential procedures: calendar versus information time. , 1989, Statistics in medicine.
[51] D L DeMets,et al. Changing frequency of interim analysis in sequential monitoring. , 1989, Biometrics.
[52] K. Bailey,et al. Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. , 1989, Biometrics.
[53] W. Rogers,et al. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.
[54] K K Lan,et al. The B-value: a tool for monitoring data. , 1988, Biometrics.
[55] Raymond J. Carroll,et al. Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process , 1988 .
[56] E. Lakatos,et al. Sample sizes based on the log-rank statistic in complex clinical trials. , 1988, Biometrics.
[57] M C Wu,et al. Sample size for comparison of changes in the presence of right censoring caused by death, withdrawal, and staggered entry. , 1988, Controlled clinical trials.
[58] K. Bailey,et al. Analysing changes in the presence of informative right censoring caused by death and withdrawal. , 1988, Statistics in medicine.
[59] E. Lakatos,et al. Sample size determination in clinical trials with time-dependent rates of losses and noncompliance. , 1986, Controlled clinical trials.
[60] D. Spodick. Multiple risk factor intervention trial. , 1985, The American journal of cardiology.
[61] Raymond J. Carroll,et al. On errors-in-variables for binary regression models , 1984 .
[62] Cass Principal Investigators and Their Associates. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. , 1984, The New England journal of medicine.
[63] Effects of antenatal dexamethasone administration in the infant: long-term follow-up. , 1984, The Journal of pediatrics.
[64] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[65] Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. A clinical trial. , 1983, Annals of internal medicine.
[66] David L. DeMets,et al. Asymmetric group sequential boundaries for monitoring clinical trials , 1982 .
[67] D L DeMets,et al. An aid to data monitoring in long-term clinical trials. , 1982, Controlled clinical trials.
[68] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[69] D. DeMets,et al. Early stopping in the two-sample problem for bounded random variables. , 1982, Controlled clinical trials.
[70] W C Blackwelder,et al. "Proving the null hypothesis" in clinical trials. , 1981, Controlled clinical trials.
[71] K. K. Lan,et al. Stochastically curtailed tests in long–term clinical trials , 1982 .
[72] A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. , 1982, JAMA.
[73] Joseph J. Smith. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. , 1981, American journal of obstetrics and gynecology.
[74] Practical aspects of decision making in clinical trials: the coronary drug project as a case study. The Coronary Drug Project Research Group. , 1981, Controlled clinical trials.
[75] D. DeMets,et al. Sample sizes for long-term medical trial with time-dependent dropout and event rates. , 1980, Controlled clinical trials.
[76] David L. DeMets,et al. Group sequential methods for clinical trials with a one-sided hypothesis , 1980 .
[77] Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. , 1980, Annals of internal medicine.
[78] J. Ware,et al. On the relation between blood pressure change and initial value. , 1980, Journal of chronic diseases.
[79] Anna C. Balazs,et al. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. , 1980, The New England journal of medicine.
[80] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[81] P. Canner. Monitoring treatment differences in long-term clinical trials. , 1977, Biometrics.
[82] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[83] James H. Ware,et al. On distribution-free tests for equality of survival distributions , 1977 .
[84] M. Halperin,et al. Early Decision in a Censored Wilcoxon Two-Sample Test for Accumulating Survival Data , 1974 .
[85] Ralph,et al. The Coronary Drug Project: Design, Methods, and Baseline Results , 1973, Circulation.
[86] J Cornfield,et al. The Bayesian outlook and its application. , 1969, Biometrics.
[87] Max Halperin,et al. An Adaptive Procedure for Sequential Clinical Trials , 1969 .
[88] E. Buskirk. The National Diet-Heart Study Final Report. , 1969, Circulation.
[89] B. M. Baker,et al. Ballistocardiography: Predictor of Coronary Heart Disease , 1968, Circulation.
[90] J. Cornfield,et al. A multivariate analysis of the risk of coronary heart disease in Framingham. , 1967, Journal of chronic diseases.
[91] J. Cornfield. A BAYESIAN TEST OF SOME CLASSICAL HYPOTHESES- WITH APPLICATIONS TO SEQUENTIAL CLINICAL TRIALS , 1966 .
[92] D. Alling. Closed sequential tests for binomial probabilities. , 1966, Biometrika.
[93] J. Cornfield. Sequential Trials, Sequential Analysis and the Likelihood Principle , 1966 .
[94] W. Kannel,et al. Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.
[95] T. Dawber,et al. Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.
[96] John Wishart,et al. GROWTH-RATE DETERMINATIONS IN NUTRITION STUDIES WITH THE BACON PIG, AND THEIR ANALYSIS , 1938 .